BDI-International Magazine - Inaugural Issue
Best Doctors Insurance magazine
Best Doctors Insurance magazine
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Members of the award-winning UHealth Tower Stroke Team, from left, David Lang, D.O., Christina Pacheco, Eldorana Pust, Aliercy Nunez<br />
Sanchez, Tara Michelle Cheung, RN, Sebastian Koch, M.D., Michael Greenberg, M.D., Shane Soorus, RN, Julianne Lee Burgos, Betty Hanley,<br />
Cathy Rosenberg, MSN, ARNP-BC, Amanda Demane, SLP, and Miguel Garcia.<br />
ensuring that stroke patients receive the<br />
most appropriate treatment according to<br />
nationally recognized, research-based<br />
guidelines based on the latest scientific<br />
evidence.<br />
UHealth Tower earned the award by<br />
meeting specific quality achievement<br />
measures for the diagnosis and treatment<br />
of stroke patients at a set level for a<br />
designated period. These measures<br />
include evaluation of the proper use of<br />
medications and other stroke treatments<br />
aligned with the most up-to-date,<br />
evidence-based guidelines with the goal<br />
of speeding recovery and reducing death<br />
and disability for stroke patients.<br />
“UHealth Tower is dedicated to improving<br />
the quality of care for our stroke patients<br />
by implementing the American Heart<br />
Association’s Get With The Guidelines-<br />
Stroke initiative,” said Sebastian Koch,<br />
M.D., professor of clinical neurology and<br />
chief of the Stroke Program at UHealth<br />
Tower. “The tools and resources provided<br />
help us track and measure our success in<br />
meeting evidenced-based clinical<br />
guidelines developed to improve patient<br />
outcomes.”<br />
UHealth Tower additionally received the<br />
AHA/ASA Target: Stroke Elite Plus<br />
Award. To qualify for this recognition,<br />
hospitals must meet quality measures<br />
developed to reduce the time between the<br />
patient’s arrival at the hospital and<br />
treatment with the clot-buster tissue<br />
plasminogen activator, or tPA, the only<br />
drug approved by the U.S. Food and Drug<br />
Administration to treat ischemic stroke.<br />
Specifically, the hospital has achieved an<br />
average time to thrombolytic therapy<br />
within 60 minutes in 75 percent or more<br />
of acute ischemic stroke patients treated<br />
with IV tPA and door-to-needle time<br />
within 45 minutes in 50 percent of acute<br />
ischemic stroke patients treated with IV<br />
tPA.<br />
“These awards represent the highest<br />
category of stroke center awards given by<br />
the AHA,” said David Sinclair, M.D.,<br />
M.B.A., UHealth chief patient safety and<br />
quality officer. “They are truly a great<br />
achievement and the result of tremendous<br />
work and dedication by a terrific<br />
multidisciplinary team.”<br />
<strong>BDI</strong> <strong>International</strong> <strong>Magazine</strong> | Page 20